Journal Article FZJ-2021-02678

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
On the consensus nomenclature rules for radiopharmaceutical chemistry – Reconsideration of radiochemical conversion

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2021
Elsevier Science Amsterdam [u.a.]

Nuclear medicine and biology 93, 19 - 21 () [10.1016/j.nucmedbio.2020.11.003]

This record in other databases:      

Please use a persistent id in citations:   doi:

Abstract: Radiochemical conversion is an important term to be included in the “Consensus nomenclature rules for radiopharmaceuticalchemistry”. Radiochemical conversion should be used to define reaction efficiency by measuringthe transformation of components in a crude reactionmixture at a given time,whereas radiochemical yield is bettersuited to define the efficiency of an entire reaction process including, for example, separation, isolation, filtration,and formulation.

Classification:

Contributing Institute(s):
  1. Nuklearchemie (INM-5)
Research Program(s):
  1. 5253 - Neuroimaging (POF4-525) (POF4-525)

Appears in the scientific report 2021
Database coverage:
Medline ; Embargoed OpenAccess ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; Ebsco Academic Search ; Essential Science Indicators ; IF < 5 ; JCR ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Dokumenttypen > Aufsätze > Zeitschriftenaufsätze
Institutssammlungen > INM > INM-5
Workflowsammlungen > Öffentliche Einträge
Publikationsdatenbank
Open Access

 Datensatz erzeugt am 2021-06-22, letzte Änderung am 2022-02-10


Published on 2020-11-18. Available in OpenAccess from 2021-11-18.:
Volltext herunterladen DOCX
(zusätzliche Dateien)
Externer link:
Volltext herunterladenFulltext by OpenAccess repository
Dieses Dokument bewerten:

Rate this document:
1
2
3
 
(Bisher nicht rezensiert)